Covered recipient · General Payments record
CHRISTOPHER HORD
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2022–2024
$744.96
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $436.09 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $269.46 | 18 |
| GlaxoSmithKline, LLC. | $72.31 | 4 |
| Lilly USA, LLC | $34.74 | 2 |
| Gilead Sciences, Inc. | $23.98 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.29 | 1 |
| Acerta Pharma LLC | $13.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.69 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355861 | CMS |
| ABBVIE INC. | $10.89 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355863 | CMS |
| ABBVIE INC. | $24.42 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355865 | CMS |
| ABBVIE INC. | $3.71 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355867 | CMS |
| ABBVIE INC. | $8.13 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355869 | CMS |
| ABBVIE INC. | $15.10 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355871 | CMS |
| ABBVIE INC. | $26.08 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355873 | CMS |
| ABBVIE INC. | $15.49 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355875 | CMS |
| ABBVIE INC. | $17.87 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355877 | CMS |
| ABBVIE INC. | $0.43 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355879 | CMS |
| ABBVIE INC. | $11.92 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355881 | CMS |
| ABBVIE INC. | $15.86 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355883 | CMS |
| ABBVIE INC. | $20.18 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355885 | CMS |
| ABBVIE INC. | $17.90 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355887 | CMS |
| ABBVIE INC. | $13.00 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355889 | CMS |
| ABBVIE INC. | $14.26 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355891 | CMS |
| ABBVIE INC. | $24.16 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355893 | CMS |
| ABBVIE INC. | $20.37 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107355895 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.31 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104493068 | CMS |
| Gilead Sciences, Inc. | $23.98 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133728957 | CMS |
| GlaxoSmithKline, LLC. | $18.23 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116358401 | CMS |
| GlaxoSmithKline, LLC. | $17.17 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116579691 | CMS |
| GlaxoSmithKline, LLC. | $17.17 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116514193 | CMS |
| GlaxoSmithKline, LLC. | $19.74 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115985108 | CMS |
| Lilly USA, LLC | $17.80 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135590860 | CMS |
| Lilly USA, LLC | $16.94 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135613544 | CMS |
| Novartis Pharmaceuticals Corporation | $22.29 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086944443 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.